Company Update Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Gland Pharma receives a tentative approval from the US FDA for Angiotensin II for Injection, 2.5 mg/ml Single-dose vial